Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Similar articles for PubMed (Select 22023378)

1.

Systematic review of cancer presentations with a median survival of six months or less.

Salpeter SR, Malter DS, Luo EJ, Lin AY, Stuart B.

J Palliat Med. 2012 Feb;15(2):175-85. doi: 10.1089/jpm.2011.0192. Epub 2011 Oct 24. Review.

PMID:
22023378
2.

Systematic review of noncancer presentations with a median survival of 6 months or less.

Salpeter SR, Luo EJ, Malter DS, Stuart B.

Am J Med. 2012 May;125(5):512.e1-6. doi: 10.1016/j.amjmed.2011.07.028. Epub 2011 Oct 24. Review.

PMID:
22030293
3.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
4.

Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review.

Hauser CA, Stockler MR, Tattersall MH.

Support Care Cancer. 2006 Oct;14(10):999-1011. Epub 2006 May 18. Review.

PMID:
16708213
5.

The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A.

Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. Review.

6.

Clinical survival predictors in patients with advanced cancer.

Viganó A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME.

Arch Intern Med. 2000 Mar 27;160(6):861-8.

PMID:
10737287
7.

Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis.

Ludbrook JJ, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1321-30. Review.

PMID:
12654444
8.

Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors.

Barbot AC, Mussault P, Ingrand P, Tourani JM.

J Clin Oncol. 2008 May 20;26(15):2538-43. doi: 10.1200/JCO.2007.14.9518.

9.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

10.

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.

Bajorin DF, Dodd PM, Mazumdar M, Fazzari M, McCaffrey JA, Scher HI, Herr H, Higgins G, Boyle MG.

J Clin Oncol. 1999 Oct;17(10):3173-81.

PMID:
10506615
11.

Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study.

Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D.

Cancer. 1995 May 15;75(10):2613-22.

PMID:
7537625
12.

Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.

Glare PA, Eychmueller S, McMahon P.

J Clin Oncol. 2004 Dec 1;22(23):4823-8. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

13.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
14.

Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.

Eralp Y, Saip P, Sakar B, Kucucuk S, Aydiner A, Dincer M, Aslay I, Topuz E.

Int J Gynecol Cancer. 2003 Jul-Aug;13(4):497-504.

PMID:
12911727
15.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
16.

Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.

Cartei G, Cartei F, Cantone A, Causarano D, Genco G, Tobaldin A, Interlandi G, Giraldi T.

J Natl Cancer Inst. 1993 May 19;85(10):794-800.

PMID:
8387607
17.

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S.

Gynecol Oncol. 2002 Jun;85(3):487-92.

PMID:
12051879
18.

Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?

Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):297-302.

PMID:
10661335
20.

Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.

Graham MV, Geitz LM, Byhardt R, Asbell S, Roach M 3rd, Urtasun RC, Curran WJ Jr, Lattin P, Russell AH, Cox JD.

J Natl Cancer Inst. 1992 Nov 18;84(22):1731-5.

PMID:
1331484
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk